Healthcare - Biotechnology - NASDAQ - US
$ 17.72
-4.06 %
$ 1.52 B
Market Cap
-3.92
P/E
INCOME STATEMENT
145 M
REVENUE
-377 M
OPERATING INCOME
-376 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Travere Therapeutics, Inc.
| Revenue | 145 M |
| Cost Of Revenue | 11.4 M |
| Gross Profit | 134 M |
| Operating Expenses | 472 M |
| Operating Income | -377 M |
| Other Expenses | -411 K |
| Net Income | -376 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Feb-2012 | Feb-2011 | Feb-2010 | Feb-2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||
| Revenue | 145.2 | 212.0 | 227.5 | 198.3 | 175.3 | 164.2 | 154.9 | 133.6 | 99.9 | 28.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||||||||||
| Cost Of Revenue | 11.4 | 7.6 | 6.8 | 6.1 | 5.2 | 5.5 | 3.6 | 4.6 | 2.2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 133.8 | 204.4 | 220.7 | 192.2 | 170.1 | 158.7 | 151.3 | 129.0 | 97.7 | 27.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | ||||||||||||||||
| Operating Expenses | 472.0 | 456.0 | 360.2 | 267.6 | 269.9 | 227.4 | 182.1 | 168.9 | 130.0 | 107.4 | 24.0 | 30.3 | 12.8 K | 0 | 0 | 13.4 K |
| Selling, General and Administrative Expenses | 265.5 | 220.2 | 149.9 | 135.8 | 129.0 | 103.7 | 104.0 | 98.0 | 79.5 | 59.6 | 16.9 | 30.3 | 12.8 K | 0 | 0 | 13.4 K |
| Research and Development Expenses | 245.0 | 235.8 | 210.3 | 131.8 | 141.0 | 123.8 | 78.2 | 70.9 | 50.4 | 47.8 | 7.1 | 0.7 | 0 | 0 | 0 | 0 |
| Operating Income | (376.7) | (251.6) | (139.5) | (75.4) | (99.8) | (80.0) | (53.8) | (58.2) | (50.7) | (79.8) | (24.0) | (30.2) | 12.8 K | 0 | 0 | 18.3 K |
| PRE-TAX INCOME | ||||||||||||||||
| Interest Income Expense | 11.3 | 11.3 | 20.1 | 19.1 | 18.8 | 9.8 | 1.2 | 34.5 | 7.7 | 55.0 | 19.5 | 0.1 | 2 K | 0 | 0 | 0 |
| Total Other Income | 0.6 | (11.3) | 19.7 | (113.4) | (46.6) | (21.8) | (30.2) | (23.9) | 156.2 | (33.9) | (9.8) | 86.8 K | 2 K | 0 | 0 | 0 |
| Pre-Tax Income | (376.1) | (278.2) | (179.7) | (188.8) | (146.4) | (101.9) | (58.4) | (57.6) | 105.5 | (113.4) | (33.7) | (30.3) | 14.8 K | 0 | 0 | 18.3 K |
| NET INCOME | ||||||||||||||||
| Tax Provision | 0.2 | 0.3 | 0.4 | (19.4) | 21 K | 0.8 | 1.4 | (9.7) | (11.8) | (2.5) | 75.8 K | 2.75 K | 0 | 0 | 0 | 0 |
| Net Income | (111.4) | (278.5) | (180.1) | (169.4) | (146.4) | (102.7) | (59.7) | (47.9) | 117.2 | (110.9) | (33.8) | (30.3) | 14.8 K | 0 | 0 | 18.3 K |
| EPS | 1.5 | 4.37 | 3.01 | 3.56 | 3.46 | 2.54 | 1.54 | 1.29 | 3.49 | 4.43 | 2.38 | 8.29 | 0.14 | 0 | 0 | 0.0002 |